Voyageur Pharmaceuticals Ltd.
VYYRF
$0.13
$0.0218.90%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -145.72% | 32.24% | -71.41% | -27.70% | 36.76% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -33.33% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.99% | -28.26% | 369.60% | 14.67% | -70.88% |
| Change in Net Operating Assets | 10,461.54% | 99.81% | -303.47% | 40.12% | 154.08% |
| Cash from Operations | -247.30% | 80.76% | -1,733.05% | 106.29% | 120.59% |
| Capital Expenditure | -474.66% | 50.68% | -15.18% | 36.07% | -43.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -474.66% | 50.68% | -15.18% | 36.07% | -43.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,709.09% | -94.40% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.15% | -124.48% | 143.27% | -- | 100.00% |
| Cash from Financing | 7,651.70% | -98.89% | 1,461.32% | 1,968.29% | 161.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 322.18% | -156.02% | 180.10% | 1,695.95% | 95.74% |